UCB's VIMPAT® (lacosamide) CV now approved by FDA for primary generalized tonic-clonic seizures and expanded pediatric use for people living with epilepsy
These highlights do not include all the information needed to use LACOSAMIDE INJECTION safely and effectively. See full prescribing information for LACOSAMIDE INJECTION. LACOSAMIDE injection, for intravenous use, CV Initial U.S. Approval:
Vimpat: Package Insert / Prescribing Information - Drugs.com
Buy Vimpat lacosamide 50mg film-coated tablet 1's online with MedsGo. Price - from
Vimpat: Package Insert / Prescribing Information - Drugs.com
LACOSAMIDE ORAL SOLUTION solution
Vimpat: Package Insert / Prescribing Information - Drugs.com
Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine - ScienceDirect
Effect of lacosamide on ethanol induced conditioned place preference and withdrawal associated behavior in mice: Possible contribution of hippocampal CRMP-2 - ScienceDirect
Vimpat: Package Insert / Prescribing Information - Drugs.com
Lacosamide - wikidoc
Vimpat: Package Insert / Prescribing Information - Drugs.com
Phase 3 data on VIMPAT® (lacosamide) CV in primary generalized tonic-clonic seizures published in Journal of Neurology, Neurosurgery & Psychiatry | BioSpace